Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Andersen Products is a private medical device and sterilization company focused on ethylene oxide sterilization systems and related services for healthcare, laboratory, veterinary, and medical device customers. The company traces its origins to 1956 and the UK entity H.W. Andersen Products Limited was incorporated in 1973. Its offerings include low-temperature ethylene oxide sterilizers such as the Anprolene and EOGas product lines, along with contract sterilization services and associated consumables. Andersen positions its EO-Flexible Chamber Technology as a differentiated platform designed to reduce ethylene oxide use while enabling terminal sterilization of delicate and complex devices, including endoscopes and drug-coated products. The business serves hospitals, clinics, research laboratories, dentists, veterinarians, and medical device manufacturers globally, with European operations centered in Essex and group manufacturing and R&D in North Carolina.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on H.W. Andersen Products.